FIGURE 1.
Distribution of patients with PE by age group.
FIGURE 2.
Most frequently identified risk factors for PE.
FIGURE 3.
Incidence of PE in relation to COVID-19 infection or vaccination.
TABLE 1.
The prevalence of signs and symptoms of PE.
| Sign or symptom | n | % |
|---|---|---|
| Dyspnea | 64 | 65.97 |
| Lower limb pain or edema | 43 | 44.33 |
| Chest pain | 34 | 35.05 |
| Syncope | 10 | 10.30 |
| Fever | 10 | 10.30 |
| Hemoptysis | 3 | 3.09 |
FIGURE 4.
Inflammatory markers in COVID-19 and non-COVID-19 subgroups.
FIGURE 5.
Anatomical location of PE.
FIGURE 6.
Prognostic characteristics of COVID-19 and non-COVID-19 subgroups.